CELL AND GENE THERAPY INSIGHTS

May 2022 Issue

Volume 8 Issue 4

Cell and Gene Therapy Insights Volume 8 Issue 4
Download PDF

Featuring

Issue Spotlight: Gene delivery/gene editing platform evolution
Vectors focus: Vector characterization 2022
Other articles
Webinars

SPOTLIGHT

Gene delivery/gene editing platform evolution

Foreword

Gene delivery & gene editing platform evolution

Gene delivery & gene editing platform evolution

Louise Rodino-Klapac
20 May 2022
Read

Expert Insight

Engineered exosomes: a transformative therapeutic modality

Engineered exosomes: a transformative therapeutic modality

P Jones, D Carter, D Lowe et al.
25 May 2022
Read
Unleashing the full potential of cell therapy through RNA engineering

Unleashing the full potential of cell therapy through RNA engineering

Metin Kurtoglu
11 May 2022
Read

Innovator Insight

Process & analytical insights for GMP manufacturing of mRNA lipid nanoparticles

Process & analytical insights for GMP manufacturing of mRNA lipid nanoparticles

E Cameau, P Zhang, S Ip et al.
3 July 2022
Read

Commentary

Therapeutic mRNA delivery with targeted lipid nanoparticles: next-generation transformative medicines

Therapeutic mRNA delivery with targeted lipid nanoparticles: next-generation transformative medicines

Umar Iqbal, Jagdeep K Sandhu
27 March 2022
Read

FastFacts

Accelerating adherent cell production for diabetes gene therapy using a scalable fixed-bed bioreactor platform

Accelerating adherent cell production for diabetes gene therapy using a scalable fixed-bed bioreactor platform

Tom Bongiorno
21 May 2022
Read

Interview

Encouraging signs for a new generation of AAV-driven gene therapy

Encouraging signs for a new generation of AAV-driven gene therapy

Dr Katherine A High
24 May 2022
Read
Breaking new ground in the clinical application of CRISPR/Cas9

Breaking new ground in the clinical application of CRISPR/Cas9

Laura Sepp-Lorenzino
10 May 2022
Read
Evolution in gene therapy for the treatment of hemophilia

Evolution in gene therapy for the treatment of hemophilia

Roland W Herzog, PhD
2 April 2022
Read

Vectors FOCUS

Vector characterization 2022

Innovator Insight

Simplifying analytical development of viral vector production: robust and sensitive methods for common expression systems

Simplifying analytical development of viral vector production: robust and sensitive methods for common expression systems

Srinath Kashi Ranganath
16 July 2022
Read

FastFacts

Characterization of advanced therapies: leveraging advanced analytics to avoid FDA holds

Characterization of advanced therapies: leveraging advanced analytics to avoid FDA holds

Dana Cipriano, Alexei Saveliev
10 July 2022
Read

Viewpoint

The present hurdles and opportunities in our knowledge of AAV basic biology

The present hurdles and opportunities in our knowledge of AAV basic biology

Bijay Dhungel, John Rasko
17 May 2022
Read

Interview

AAV vector characterization best practices

AAV vector characterization best practices

Gaël Stephant
17 May 2022
Read

articles

Poster

Applications and benefits of the CTS Rotea Counterflow Centrifugation System in cell therapy workflows

Applications and benefits of the CTS Rotea Counterflow Centrifugation System in cell therapy workflows

Carl Dargitz
11 May 2022
Read
A pan-affinity resin for efficient AAV purification: a CDMO perspective

A pan-affinity resin for efficient AAV purification: a CDMO perspective

Vincent Ravault
7 May 2022
Read

Podcast

The quest for the Holy Grail in AAV chromatography: empty–full separation

The quest for the Holy Grail in AAV chromatography: empty–full separation

Ratish Krishnan, Oliver Rammo
19 May 2022
Listen

Viewpoint

A new wave of allogeneic CAR-T cell therapies in oncology treatment

A new wave of allogeneic CAR-T cell therapies in oncology treatment

Silvan Tuerkcan, PhD
20 May 2022
Read
Overcoming the immune-related shortfalls of AAV

Overcoming the immune-related shortfalls of AAV

Genine Winslow
10 May 2022
Read

Interview

Trends and considerations in cell and gene therapy M&A, partnering and IP

Trends and considerations in cell and gene therapy M&A, partnering and IP

Ewan Townsend
11 May 2022
Read

Webinars